Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 1 | Journal of Medical Case Reports

Figure 1

From: The emergence of non-secretory multiple myeloma during the non-cytotoxic treatment of essential thrombocythemia: a case report

Figure 1

Histological and immunohistochemical analysis of essential thrombocythemia and multiple myeloma. (a) Initial bone marrow biopsy specimen when essential thrombocythemia was diagnosed (Giemsa, ×200). (b) Bone marrow biopsy specimen when multiple myeloma (MM) was diagnosed showing the diffuse infiltration with plasma cells (Giemsa, ×200). (c) Bone marrow biopsy specimen when MM was diagnosed showing the kappa positive plasma cells (×200). (d) Bone marrow biopsy specimen when MM was diagnosed showing the CD138 positive plasma cells (×200). (e) Bone marrow biopsy specimen after MM chemotherapy showing the diffuse infiltration with plasma cells (Giemsa, ×200). (f) Bone marrow biopsy specimen after MM chemotherapy showing the CD138 positive plasma cells (×200).

Back to article page